ECASS 3 Study Receives Recognition From the European Stroke Organisation and The Lancet

Boehringer Ingelheim []
Ingelheim, Germany (ots/PRNewswire) – – ESO Recommends Extended Time Window for Actilyse(R) INGELHEIM, Germany, January 30 /PRNewswire/ — – For Healthcare Media outside the U.S.A., Canada, and Japan Based on key …

Quelle: Presseportal.de – Branche Gesundheit/Medizin